Facial Nerve Palsy

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: April 27, 2026Bookmark

Facial nerve palsy is the weakness or paralysis of facial muscles due to pathology of the facial nerve.

Course of the facial nerve

SegmentDescription
IntracranialThe motor nucleus is situated in the pons and emerges through the cerebellopontine angle to be joined by the nervus intermedius (contains the sensory and autonomic components of the facial nerve). It enters the internal acoustic meatus, which is located in the petrous part of the temporal bone. No branches are given at this point. It travels with the following in the internal acoustic meatus: superior and inferior vestibular nerves, cochlear nerve, labyrinthine artery, and vestibular ganglion
IntratemporalThis spans its course from the internal acoustic meatus to its exit through the stylomastoid foramen. It can be further divided into: labyrinthine segment (IAM to geniculate ganglion/first Genu). This is the narrowest portion of the nerve; thus, this is where it is most sensitive to injury. It gives off the greater petrosal nerve. Segment: tympanic segment (geniculate ganglion to second genu); and mastoid segment (second genu to stylomastoid foramen). The nerve to the stapedius and chorda tympani branches leave at this point.
ExtracranialSpans from the stylomastoid foramen to its terminal branches in the parotid gland.

Branches of the facial nerve

BranchInnervation
Greater petrosal nerveParasympathetic innervation to the lacrimal, palatine and nasal glands
Chorda tympaniParasympathetic innervation of the submandibular and sublingual glands. Sensory innervation to the anterior two-thirds of the tongue.
Nerve to the stapediusMotor to stapedius
Branches to occipitals, digastric, and stylohyoid musclesMotor to occipitals, digastric, and stylohyoid muscles
Temporal branchMotor to the frontalis to raise eyebrows
Zygomatic branchMotor to orbicularis oculi to close eyes
Buccal branchMotor to buccinator to puff cheeks
Mandibular branchMotor to show the bottom teeth
Cervical branchPlatysma to tense neck

Causes of facial nerve palsy by anatomic region

ClassificationCause
CentralBrain abscess, pontine gliomas, poliomyelitis, multiple sclerosis, stroke or TIA
IntracranialAcoustic neuroma, meningioma, congenital cholesteatoma, metastasis, meningitis
IntratemporalIdiopathic (Bell’s palsy), Infections (acute and chronic otitis media), trauma (accidental, iatrogenic), neoplasms
ExtracranialMalignancy of the parotid, injury to the parotid gland
Systemic diseaseDiabetes, hypothyroidism, uraemia, leukaemia
  • History
    • How long has the paralysis been present?
    • Was the onset sudden or slowly progressive?
    • Does it affect all nerve distribution or only part of the face?
    • Associated symptoms
      • Ear pain
      • Fever
      • Preceding viral illness
      • Vascular symptoms such as a stroke or TIA
      • Trauma
      • Parotid mass
  • Physical examination
    • Full head and neck examination, including the ears
    • Palpation of the parotid gland and face for masses
    • Cranial nerve examination with an emphasis on the facial nerve and facial muscle function:
      • Wrinkling of the forehead, keeping eyes closed against resistance to opening, smiling to show teeth, and frowning
    • Blink test
      • Tapping the labella should stimulate blinking
    • Schirmer test
      • A test for lacrimation using blotting paper
    • Stapedial test
      • Tests sensitivity to loud sounds. This is done via tympanometry
    • Salivary test
      • The salivation rate is assessed from a submandibular duct after stimulation with a 6% citric acid solution
    • Taste test using salt, sweet, sour, and bitter tastes along the lateral aspects of the anterior two-thirds of the tongue
  • Investigations
    • Nerve conduction studies
    • Complete Blood Count
    • C-reactive protein
    • UECs
    • VZV antibody titres
    • Immunoglobulin titres
      • Elevated in Lyme disease
    • Imaging studies (Ultrasound, CT or MRI) for trauma or malignancy
    • Audiogram if there is hearing loss
  • Treatment
    • Eye care
      • Artificial tears
      • Taping the eye closed at night
    • Facial muscle therapy and massage
    • Bell’s palsy is treated with steroids (prednisolone) and analgesics
    • Ramsay Hunt syndrome is treated with steroids (prednisolone), analgesia, and antivirals (acyclovir)
    • Surgery
      • Facial nerve decompression
      • Facial nerve repair and grafting
  • Poor prognostic factors
    • Age >50 years
    • Complete palsy
    • Loss of acoustic reflex
    • Ramsay Hunt Syndrome
    • Poor electrophysiological test results
    • No signs of recovery after three weeks of treatment
    • Associated comorbidities such as hypertension, diabetes, and pregnancy
  • Complications
    • Exposure keratitis
    • Disfigurement
    • Hemifacial spasm
    • Synkinesis – the involuntary contraction of facial muscles occurring simultaneously with a voluntary movement, typically after facial nerve palsy has recovered

House Brackman grading system – Normal Function to complete paralysis

GradeDescription
INormal, symmetrical function
IISlight weakness is obvious on close inspection, slight asymmetry of the smile
IIIObvious, non-disfiguring weakness, complete eye closure
IVObvious, disfiguring weakness, inability to completely close eyes, and lift eyebrows. Normal facial symmetry at rest
VBarely perceptible facial motion; asymmetry at rest
VIComplete paralysis
GradeFunction levelSymmetry at RestEye(s)MouthForehead
INormalNormalNormalNormalNormal
IIMildNormalEasy and complete closureSlightly asymmetricalReasonable function
IIIModerateNormalWith effort, complete closureSlightly affected with effortSlight-to moderate movement
IVModerately severeNormalIncomplete closureAsymmetrical with maximum effortNone
VSevereAsymmetryIncomplete closureMinimal movementNone
VITotal paralysisTotal paralysisTotal paralysisTotal paralysisTotal paralysis

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team